Sai Life Sciences hosts Biotech Pitch Day 2026 at Boston Site

Sai Life Sciences successfully hosted its Biotech Pitch Day 2026 at its Boston-area site on March 19, bringing together a dynamic group of emerging biotech innovators, scientific leaders, and industry experts.

The event was designed as a platform for early-stage biotech companies to showcase their science, strengthen visibility, and engage with potential collaborators across the drug discovery ecosystem. As part of this initiative, participating startups also gain the opportunity to work with Sai Life Sciences—leveraging its integrated drug discovery capabilities, scientific expertise, and infrastructure to help advance their programs.

Selected from a competitive pool of applicants, ten promising startups were invited to present their work to a distinguished panel of judges and engage in meaningful discussions with peers and mentors.

Finalist Cohort
The finalists included:
Zena Therapeutics Inc., Luciole Pharmaceuticals, Inc., NuCyRNA Therapeutics, Myracle Therapeutics, AudazBio, Inc., Block Biosciences, Weld Pharmaceuticals, Cryptyx Bioscience, VISTARA BIOSCIENCE, and Neuropathix, Inc.

Recognizing Standout Innovators
Following a day of engaging presentations and discussions, three companies were recognized for their exceptional scientific rigor and compelling vision:
Block Biosciences
Neuropathix, Inc.
Zena Therapeutics Inc.
Special recognition was also extended to Cryptyx Bioscience and Tag Team Therapeutics for their strong and thoughtful pitches.

Expert Evaluation and Industry Engagement
The presentations were evaluated by an esteemed panel of judges, including Daniel Resnicow, Stephanos Ioannidis, Bharat Lagu, and Arjun Goyal. Their insights and feedback contributed to a highly engaging and enriching experience for all participants.

Driving Future Partnerships
The event builds on Sai Life Sciences’ broader initiative to support biotech startups through access to scientific expertise, infrastructure, and collaborative opportunities. Participants gained deeper visibility into Sai’s integrated drug discovery platform and explored potential pathways for collaboration.
With strong participation, high-quality science, and vibrant discussions, the Biotech Pitch Day underscored the growing importance of collaborative platforms in accelerating innovation.
Sai Life Sciences looks forward to continuing these conversations and building meaningful partnerships with the biotech community.